Gifts From Pharmaceutical Companies Influence Prescribing Habits Across Multiple Specialties
According to a new study, receipt of gifts from pharmaceutical companies is associated with more prescriptions per patient and more costly prescriptions.
Diagnosis & Disease Information
Physician Insights on Prescribing Habits: Are Clinicians Being Swindled?
Are we being thoughtful with our prescribing habits?
Change in Generic Drug Prices Linked to Market Competition
The study noted a price change of -31.7% for quadropoly and 47.4% for monopoly.
FDA Aims to Increase Number of Generic Drugs on the Market
The agency will now give priority reviews to new generic drugs until there are at least 3 available.
Former Pharma Representatives Being Used by Health Insurers to Lower Costs
Former pharma reps are educating doctors about costs of medications and encouraging the use of generic drugs.
Dermatologists Shown to Receive Significant Industry Payments from Pharmaceuticals
Dermatologists receive variations in nature and amount of payments from pharmaceutical companies, with the top 1% receiving at least $93,622.
First Ever Drug for Duchenne Muscular Dystrophy Approved by FDA
The FDA has just approved the drug, Exondys 51, to treat patients with a mutation of the dystrophin gene amenable to exon 51 skipping in DMD.
Mylan to Release Generic Version of EpiPen® In Continued Effort to Lower Costs
According to Mylan, the first generic version of EpiPen® will be distributed in several weeks in an attempt to further lower the costs of attaining this life-saving medication.
Mylan Takes Action To Lower Cost of EpiPens
The pharmaceutical company has outlined steps to lower the financial burden of acquiring their products after price hike.
- Loading...
Loading...
Loading... 
Loading...